EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Prednisolone pharmacokinetics in dogs with protein-losing enteropathy

Sara A Jablonski iD, Jessica L Strohmeyer, John P Buchweitz, Andreas F Lehner, Daniel K Langlois iD

Journal of Veterinary Internal Medicine · 2025

DOI: 10.1111/jvim.17277 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Veterinary Internal Medicine, 2025. Verfasst von Sara A Jablonski und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Small Animal Clinical Sciences, College of Veterinary Medicine, Michigan State University, East Lansing, Michigan, USA. Hauptthemen laut MEDLINE: Protein-Losing Enteropathies, Prednisolone, Dog Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Michigan State University College of Veterinary Medicine Endowed Research Funds, Specifically the Della K. Swander Fund, Michigan State University College of Veterinary Medicine Trinket Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

It is unknown if glucocorticoid malabsorption contributes to the approximate 50% treatment failure rate in dogs with protein-losing enteropathy (PLE).

Objective

To compare pharmacokinetics (PK) of orally administered prednisolone in dogs with PLE vs healthy controls. Animals Fourteen dogs with well-characterized PLE and 7 control dogs.

Methods

Prospective case-controlled study. Dogs were treated with 1 mg/kg prednisolone PO once daily for approximately 3 weeks. Venous blood samples were collected at set timepoints before and after prednisolone administration on the first (T1) and final (T2) study days. Total and non-protein bound serum prednisolone concentrations were determined using liquid chromatography tandem-mass spectrometry, and pharmacokinetics variables were derived from the drug concentration data. Pharmacokinetics variables were compared between PLE and control dogs and between PLE short-term responders and non-responders.

Results

The PLE dogs had a shorter half-life of the terminal slope than control dogs (harmonic mean of 1.3 vs 1.8 hours; P = .05) whereas the percentage of serum prednisolone that was non-protein bound was higher in PLE dogs than in control dogs (median of 15.7% vs 6.7%; P = .02) at T1. Total prednisolone drug exposures and maximum total serum drug concentrations did not differ between PLE and control dogs at T1 or T2, nor did they differ between short-term responders and non-responders within the PLE population (P > .05 for all comparisons). Conclusions and Clinical Importance Overall drug exposures are similar between PLE dogs and healthy controls. Glucocorticoid malabsorption is unlikely to be a common cause of treatment failure in dogs with PLE.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein-Losing EnteropathiesPrednisoloneDog DiseasesDogsAnimalsMaleFemaleCase-Control StudiesProspective StudiesHalf-LifeGlucocorticoidsAdministration, Oral

Stichwörter der Autor:innen

chronic inflammatory enteropathyinflammatory bowel diseaselymphangiectasiatreatment

Substanzen

PrednisoloneGlucocorticoids

Autor:innen und Institutionen

  • Department of Small Animal Clinical Sciences, College of Veterinary Medicine, Michigan State University, East Lansing, Michigan, USA.
  • Department of Pathobiology and Diagnostic Investigation, College of Veterinary Medicine, Michigan State University, East Lansing, Michigan, USA.
  • Veterinary Diagnostic Laboratory, College of Veterinary Medicine, Michigan State University, East Lansing, Michigan, USA.

ORCID-Profile: Sara A Jablonski, Daniel K Langlois

Förderung

  • Michigan State University College of Veterinary Medicine Endowed Research Funds, Specifically the Della K. Swander Fund
  • Michigan State University College of Veterinary Medicine Trinket Fund

Zitieren

APA

Jablonski, S. A., Strohmeyer, J. L., Buchweitz, J. P., Lehner, A. F., & Langlois, D. K. (2025). Prednisolone pharmacokinetics in dogs with protein-losing enteropathy. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.17277

Vancouver

Jablonski SA, Strohmeyer JL, Buchweitz JP, Lehner AF, Langlois DK. Prednisolone pharmacokinetics in dogs with protein-losing enteropathy. Journal of Veterinary Internal Medicine. 2025. doi:10.1111/jvim.17277

BibTeX
@article{Jablonski2025,
  author = {Jablonski, Sara A and Strohmeyer, Jessica L and Buchweitz, John P and Lehner, Andreas F and Langlois, Daniel K},
  title = {Prednisolone pharmacokinetics in dogs with protein-losing enteropathy},
  journal = {Journal of Veterinary Internal Medicine},
  year = {2025},
  doi = {10.1111/jvim.17277}
}
Kostenlos starten →